Mirae Asset Global Investments Co., Ltd. Charles River Laboratories International, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 3,622 shares of CRL stock, worth $675,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,622
Previous 4,759
23.89%
Holding current value
$675,575
Previous $983,000
27.47%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CRL
# of Institutions
721Shares Held
52MCall Options Held
233KPut Options Held
236K-
Vanguard Group Inc Valley Forge, PA6.1MShares$1.14 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$949 Million0.02% of portfolio
-
State Street Corp Boston, MA2.09MShares$390 Million0.02% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.91MShares$356 Million0.99% of portfolio
-
Allspring Global Investments Holdings, LLC1.76MShares$328 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.49B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...